Cutaneous and Extracutaneous Manifestations of Behçet’s Disease Linked to Its Disease Activity and Prognosis

References

• Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1‐11. doi:10.1002/art.37715
   Web of Science ®Google Scholar
• Alpsoy E. Behçet’s disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620‐632. doi:10.1111/1346-8138.13381
   Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341(17):1284‐1291. doi:10.1056/NEJM199910213411707
   Web of Science ®Google Scholar
• Onder M, Gürer MA. The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol. 2001;15(2):126‐136. doi:10.1046/j.1468-3083.2001.00251.x
   Web of Science ®Google Scholar
• Lee ES, Bang D, Lee S. Dermatologic manifestation of Behçet’s disease. Yonsei Med J. 1997;38(6):380‐389. doi:10.3349/ymj.1997.38.6.380
   Google Scholar
• Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48(4):573‐585. doi:10.3349/ymj.2007.48.4.573
   Web of Science ®Google Scholar
• Mendes D, Correia M, Barbedo M, et al. Behçet’s disease–a contemporary review. J Autoimmun. 2009;32(3–4):178‐188. doi:10.1016/j.jaut.2009.02.011
   Web of Science ®Google Scholar
• Uva L, Miguel D, Pinheiro C, Filipe P, Freitas JP. Mucocutaneous manifestations of Behçet’s disease. Acta Reumatol Port. 2013;38(2):77‐90.
   Web of Science ®Google Scholar
• Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82(1):60‐76. doi:10.1097/00005792-200301000-00006
   Web of Science ®Google Scholar
• International Study Group for Behcet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335(8697):1078–1080.1970380
   PubMed Web of Science ®Google Scholar
• International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338‐347. doi:10.1111/jdv.12107.
   Web of Science ®Google Scholar
• Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38(8):728‐733. doi:10.1093/rheumatology/38.8.728
   Web of Science ®Google Scholar
• Kump LI, Moeller KL, Reed GF, Kurup SK, Nussenblatt RB, Levy-Clarke GA. Behçet’s disease: comparing 3 decades of treatment response at the National Eye Institute. Can J Ophthalmol. 2008;43(4):468‐472. doi:10.3129/i08-080
   Web of Science ®Google Scholar
• Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain. 1999;122(Pt11):2171‐2182. doi:10.1093/brain/122.11.2171
   Web of Science ®Google Scholar
• Kalra S, Silman A, Akman-Demir G, et al. Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations. J Neurol. 2014;261(9):1662‐1676. doi:10.1007/s00415-013-7209-3
   Web of Science ®Google Scholar
• Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet’s disease: a review. World J Gastroenterol. 2015;21(13):3801‐3812. doi:10.3748/wjg.v21.i13.3801
   Web of Science ®Google Scholar
• Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behçet’s disease and cardiovascular involvement. Lupus. 2005;14(9):723‐726. doi:10.1191/0961203305lu2208oa
   Web of Science ®Google Scholar
• Yazici H, Tüzün Y, Pazarli H, et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis. 1984;43(6):783‐789. doi:10.1136/ard.43.6.783
   Web of Science ®Google Scholar
• Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157(5):901‐906. doi:10.1111/j.1365-2133.2007.08116.x
   Web of Science ®Google Scholar
• Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J. 1997;38(6):423‐427. doi:10.3349/ymj.1997.38.6.423
   Google Scholar
• Mumcu G, Inanc N, Ergun T, et al. Oral health related quality of life is affected by disease activity in Behçet’s disease [published correction appears in Oral Dis. 2006 May;12(3):356]. Oral Dis. 2006;12(2):145‐151. doi:10.1111/j.1601-0825.2005.01173.x
   Web of Science ®Google Scholar
• Isogai E, Ohno S, Kotake S, et al. Chemiluminescence of neutrophils from patients with Behçet’s disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol. 1990;35(1):43‐48. doi:10.1016/0003-9969(90)90113-o
   Web of Science ®Google Scholar
• Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of BehÇet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J. 1997;38(6):444‐454. doi:10.3349/ymj.1997.38.6.444
   Google Scholar
• Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F. The oral mucosal and salivary microbial community of Behçet’s syndrome and recurrent aphthous stomatitis. J Oral Microbiol. 2015;7:27150. doi:10.3402/jom.v7.2715026037240
   PubMed Web of Science ®Google Scholar
• Theilade E, Theilade J. Formation and ecology of plaque at different locations in the mouth. Scand J Dent Res. 1985;93(2):90‐95. doi:10.1111/j.1600-0722.1985.tb01315.x
   Google Scholar
• Mays JW, Sarmadi M, Moutsopoulos NM. Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract. 2012;12(3 Suppl):265–282. doi:10.1016/S1532-3382(12)70051-923040353
   PubMedGoogle Scholar
• Ugurlu N, Bozkurt S, Bacanli A, Akman-Karakas A, Uzun S, Alpsoy E. The natural course and factors affecting severity of Behçet’s disease: a single-center cohort of 368 patients. Rheumatol Int. 2015;35(12):2103‐2107. doi:10.1007/s00296-015-3310-5
   Web of Science ®Google Scholar
• Bang DS, Oh SH, Lee KH, Lee ES, Lee SN. Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci. 2003;18(2):231‐235. doi:10.3346/jkms.2003.18.2.231
   Web of Science ®Google Scholar
• Zouboulis CC, Turnbull JR, Martus P. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet’s disease. Adv Exp Med Biol. 2003;528:123‐126. doi:10.1007/0-306-48382-3_24
   Web of Science ®Google Scholar
• Ucar-Comlekoglu D, Fox A, Sen HN. Gender differences in Behçet’s disease associated uveitis. J Ophthalmol. 2014;2014:820710. doi:10.1155/2014/82071024864195
   PubMed Web of Science ®Google Scholar
• Ishido T, Horita N, Takeuchi M, et al. Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford). 2017;56(11):1918‐1927. doi:10.1093/rheumatology/kex285
   Web of Science ®Google Scholar
• Yavuz S, Ozilhan G, Elbir Y, Tolunay A, Eksioglu-Demiralp E, Direskeneli H. Activation of neutrophils by testosterone in Behçet’s disease. Clin Exp Rheumatol. 2007;25(4 Suppl 45):S46‐S51.
   Web of Science ®Google Scholar
• Yavuz S, Akdeniz T, Hancer V, Bicakcigil M, Can M, Yanikkaya-Demirel G. Dual effects of testosterone in Behcet’s disease: implications for a role in disease pathogenesis. Genes Immun. 2016;17(6):335‐341. doi:10.1038/gene.2016.28
   Web of Science ®Google Scholar